From Heeseung to EVAN: How a Sudden Exit From ENHYPEN Turned Into K-Pop’s Biggest Solo Debut of the Year
Six months ago, ENHYPEN fans woke up to a statement none of them expected. Heeseung — one of the seven original members of one of HYBE’s flagship boy groups — was leaving the band.
Not for military service, not for a scandal, but to become a solo artist, while somehow staying at the same agency that managed the group he was exiting.
It was a strange, almost unprecedented arrangement in K-pop, and it left a trail of confused fans, unanswered questions, and a fair amount of anger in its wake.
This week, that gamble paid off in the form of hard numbers. EVAN — the name Heeseung now performs under — released his debut EP, “Death of Me,” on September 7, and by the following day, the release had become one of the more significant commercial K-pop stories of the year: a chart sweep that few solo debuts, from any label, manage to pull off.
What Actually Happened
According to Belift Lab, EVAN’s agency, “Death of Me” landed at No. 1 on iTunes’ Top Albums chart in 11 regions and charted in a total of 32 countries and regions worldwide. The title track went further on the songs side, topping iTunes’ Top Songs chart in 9 regions.
Domestically, the album sold more than 461,000 copies on its first day alone, according to Hanteo Chart — enough to claim the top spot on the daily physical album chart.
The title track also hit No. 1 on Bugs’ real-time chart within hours of release and entered Melon’s Hot 100 — reserved for songs released in the previous 30 days — at No. 5. In China, the track climbed to No. 3 on Tencent Music’s Korea chart.
Those are the figures your notes referenced, and they hold up.
It’s worth noting that early wire reports on release day (September 7–8) initially cited slightly smaller numbers — 10 regions on iTunes Albums and 7 on iTunes Songs — before outlets like The Korea Herald updated those figures to 11 and 9 respectively as the chart data settled over the following two days.
The scale of the achievement, either way, is real: EVAN’s solo bow outperformed the launches of most rookie K-pop soloists, and did so while going up against an industry calendar packed with comebacks.
The Exit That Made Headlines for the Wrong Reasons
To understand why this debut matters, it helps to rewind to March 10, 2026, when Belift Lab announced that Heeseung would be leaving ENHYPEN.
The official explanation was that “extensive discussions” among the members and the agency had revealed Heeseung had “a clear musical path he wishes to pursue,” and that the company had decided to “respect his aspirations.”
ENHYPEN would continue as a six-member group — Jungwon, Jay, Jake, Sunghoon, Sunoo, and Ni-Ki — while Heeseung pursued solo work under the same label, a structure almost never used in K-pop.
The announcement blindsided fans. Heeseung had appeared at official ENHYPEN events just days earlier, scheduled fan calls were abruptly canceled, and previously released merchandise and promotional materials still featured him — details that fueled speculation the decision wasn’t as mutual or as planned as the agency’s statement suggested.
Recommended Partner Offer
Check out featured promotions and partner deals curated for our readers.
View Partner Offer External Sponsor • Opens in New WindowA handwritten letter Heeseung posted to Weverse only deepened the questions: he wrote that leaving the group had been “suggested” by the company, a word choice that many fans seized on as evidence the exit wasn’t entirely his own decision.
A vocal wing of ENHYPEN’s fandom, ENGENE, mounted a “Justice for Heeseung” campaign, accusing Belift Lab of forcing him out.
The remaining ENHYPEN members addressed the shakeup publicly, promising fans the group would “grow stronger,” but for weeks the story dominated K-pop discourse more as a controversy than a career pivot.
Belift Lab maintained that the split reflected differences in musical direction and had nothing to do with ENHYPEN’s contract renewal, which isn’t due until November 2027.
Still, industry observers noted how rare it was for a member of a commercially thriving group to leave specifically to go solo, rather than due to conflict, health, or scandal — and that ambiguity followed Heeseung into his rebrand.
Building a Second Career From Scratch
Three months after the ENHYPEN announcement, Heeseung reemerged professionally as EVAN, releasing his first solo digital single, “Ride or Die,” on June 22.
It was a strong signal of what was coming: the track hit No. 1 on iTunes’ Top Songs chart in nine countries and regions and topped Tencent Music’s weekly Korea chart in China, while its music video climbed YouTube’s Global Daily Music Videos chart.
The months that followed were a deliberate international rollout rather than a quiet retreat. EVAN appeared at the Grammy Museum’s “Spotlight” program in Los Angeles on August 14, performed at KCON LA two days later, traveled to Hong Kong for the 2026 TIMA Awards on August 23, and returned to Korea for the K World Dream Awards on August 27 — all before “Death of Me” had even arrived.
When the EP dropped, EVAN held a debut showcase at Kyung Hee University’s Grand Peace Hall in Seoul, livestreamed to fans watching from 191 regions.
Throughout, EVAN positioned himself as the primary architect of his own material, a notable departure from the tightly centralized songwriting and production typical of major K-pop releases.
He’s credited with writing the lyrics to all eight tracks on “Death of Me” and composing the music for seven of them, with only “Noise” produced by outside writers. Belift Lab described him as having taken “a hands-on role” in producing the album “from start to finish,” building on the creative control he’d already exercised on “Ride or Die.”
The Hurdles Behind the Charts
The commercial numbers tell a triumphant story, but EVAN has been candid that the transition wasn’t easy. He’s spoken about the psychological weight of performing alone after nearly six years fronting a seven-member group — describing feeling “nervous and confused” during his earliest solo shows, with viewers picking up on visible nerves during his debut livestream on Weverse.
Commanding a stage without six other members beside him, he said, required “a distinct mental shift” he hadn’t anticipated.
Then, just days before the EP’s release, EVAN shared something he’d never discussed publicly: as a fourth grader, he was diagnosed with malignant lymphoma, a form of blood cancer.
In a Weverse Magazine interview published September 3, he described the onset — a persistent cough he assumed was a cold, followed by sudden breathlessness while playing soccer that led to the diagnosis.
He recalled trying to “put on a brave face” for his mother throughout chemotherapy, entertaining fellow child patients with guitar performances and impromptu talent shows, and watching some of those same friends lose their battles with the disease.
He also described a difficult return to ordinary life afterward — struggling to make friends, getting teased over hair that was still growing back from chemo — and admitted the memories were painful to revisit even now: “I haven’t thought about that in a long time. It hurts to bring it back up.”
EVAN has framed that history as one of the emotional foundations of “Death of Me,” describing the album as “a mirror” and “a self-portrait” rather than a literal account of leaving ENHYPEN, as some assumed.
Despite its title, he’s said the project carries a message of resilience and hope — one he hopes reaches other young cancer patients specifically. “If this story reaches them,” he said, “I want to offer them hope and comfort.”
A Complicated but Undeniable Launch
Taken together, EVAN’s solo debut is hard to categorize cleanly. Commercially, it’s an outright success — arguably a bigger opening than most rookie soloists in K-pop ever achieve, built on a self-written, self-produced album and a genuinely international promotional push.
But it arrives tangled up with an unresolved controversy over how, exactly, he ended up leaving ENHYPEN in the first place, and it’s now inseparable from a deeply personal health story he chose to share only in the EP’s final promotional stretch.
In conclusion,
Whether “Death of Me” ultimately reshapes how fans view his departure — or whether the ENHYPEN exit continues to shadow his solo career — remains an open question.
For now, the chart data is unambiguous: six months after a shaky, contested start, EVAN has one of 2026’s most commercially successful K-pop solo debuts on his hands.